<?xml version="1.0" encoding="UTF-8"?>
<p>A viable strategy for the treatment of metabolic disorders like obesity is decreasing the absorption of dietary components such as fats and carbohydrates through the inhibition of metabolic enzymes, including lipase and, again, Î±-glucosidase [
 <xref rid="B97-foods-10-00029" ref-type="bibr">97</xref>]. On the other hand, it is also necessary to act on signaling pathways that might be dysregulated as a result of obesity. Leptin is a protein involved in one such pathway; it is expressed in the adipocytes and it controls body weight and the mass of adipose tissue through the inhibition of food intake and the stimulation of energy expenditure. Defects in leptin production cause severe obesity [
 <xref rid="B98-foods-10-00029" ref-type="bibr">98</xref>].
</p>
